CN Patent

CN118201599A — 一种可平稳释放的持续性递送制剂及其制备方法

Assigned to Hunan Kelun Pharmaceutical Research Co Ltd · Expires 2024-06-14 · 2y expired

What this patent protects

一种可平稳释放的持续性递送制剂及其制备方法。该制剂包含活性药物成分和凝胶载体，该凝胶载体包含生物可降解聚合物、有机溶剂、疏水添加剂和任选的亲水凝胶骨架材料。该递送制剂相比传统Atrigel技术制备的原位凝胶，在添加少量疏水添加剂和任选的亲水凝胶骨架材料后，具有减缓药物体内外突释的效果，且体内血药浓度在安全有效范围内可维持超过一周。该制剂制备方法简单。

USPTO Abstract

一种可平稳释放的持续性递送制剂及其制备方法。该制剂包含活性药物成分和凝胶载体，该凝胶载体包含生物可降解聚合物、有机溶剂、疏水添加剂和任选的亲水凝胶骨架材料。该递送制剂相比传统Atrigel技术制备的原位凝胶，在添加少量疏水添加剂和任选的亲水凝胶骨架材料后，具有减缓药物体内外突释的效果，且体内血药浓度在安全有效范围内可维持超过一周。该制剂制备方法简单。

Drugs covered by this patent

Patent Metadata

Patent number
CN118201599A
Jurisdiction
CN
Classification
—
Expires
2024-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Hunan Kelun Pharmaceutical Research Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.